101 related articles for article (PubMed ID: 18644779)
1. Senator asks psychiatrists' association about drug company funding.
Tanne JH
BMJ; 2008 Jul; 337():a929. PubMed ID: 18644779
[No Abstract] [Full Text] [Related]
2. Drug company sponsorship of education could be replaced at a fraction of its cost.
Moynihan R
BMJ; 2003 May; 326(7400):1163. PubMed ID: 12775595
[No Abstract] [Full Text] [Related]
3. US specialty societies are urged to adopt code on relations with industry.
Tanne JH
BMJ; 2010 Apr; 340():c2246. PubMed ID: 20418248
[No Abstract] [Full Text] [Related]
4. Two views on funding. Drug firm's financial support of AMA ethics campaign poses a debate.
Romano M
Mod Healthc; 2001 Apr; 31(17):12. PubMed ID: 11338891
[No Abstract] [Full Text] [Related]
5. [Description of the French players from Avenir's investment program: the role of MabDesign].
Groux N; Pontremoli R; Vuddamalay G; Richard G; Pons D
Med Sci (Paris); 2019 Dec; 35(12):1198-1201. PubMed ID: 31903939
[No Abstract] [Full Text] [Related]
6. Premier funds biotechnology.
Scott L
Mod Healthc; 1996 Apr; 26(18):50. PubMed ID: 10157168
[No Abstract] [Full Text] [Related]
7. [The pharmaceutical industry and the funding of scientific societies].
Ferran Mercadé M
Aten Primaria; 2002 Apr; 29(6):327-8. PubMed ID: 11996710
[No Abstract] [Full Text] [Related]
8. Industry funding of patients' support groups: objectives of patients, clinicians, and industry are similar.
Lapsley PM
BMJ; 2003 Aug; 327(7410):343-4. PubMed ID: 12907504
[No Abstract] [Full Text] [Related]
9. Naming names: is there an (unbiased) doctor in the house?
Lenzer J; Brownlee S
BMJ; 2008 Jul; 337():a930. PubMed ID: 18650241
[No Abstract] [Full Text] [Related]
10. Funding alert: wake up and support WORLD.
James JS
AIDS Treat News; 2003 May; (391):6-7. PubMed ID: 12866498
[TBL] [Abstract][Full Text] [Related]
11. Generous German funding helps Ribozyme.
Alper J
Nat Biotechnol; 1998 Sep; 16(9):812. PubMed ID: 9743101
[No Abstract] [Full Text] [Related]
12. Pfizer grants $3 million to fight AIDS in US South.
AIDS Policy Law; 2003 Jun; 18(11):1. PubMed ID: 12866462
[No Abstract] [Full Text] [Related]
13. FDA to collect fees from drug companies.
Minn Med; 1992 Nov; 75(11):46. PubMed ID: 1435650
[No Abstract] [Full Text] [Related]
14. Dissent grows over Helmholtz proposals.
Abbott A
Nature; 2001 May; 411(6834):121. PubMed ID: 11346750
[No Abstract] [Full Text] [Related]
15. [MI-mAbs, pre-industrial demonstrator supported by PIA for the early validation of therapeutic targets using monoclonal antibodies].
Romagné F
Med Sci (Paris); 2019 Dec; 35(12):1202-1203. PubMed ID: 31903940
[No Abstract] [Full Text] [Related]
16. Who's funding WHO?
Day M
BMJ; 2007 Feb; 334(7589):338-40. PubMed ID: 17303876
[TBL] [Abstract][Full Text] [Related]
17. Amgen asks judge for speedy ruling in patent case.
Nephrol News Issues; 1999 Dec; 13(12):14. PubMed ID: 11984928
[No Abstract] [Full Text] [Related]
18. Scientific evidence and the courts.
Field TG
Science; 1993 Dec; 262(5140):1629-30. PubMed ID: 8110275
[No Abstract] [Full Text] [Related]
19. [Sponsorship of medical congresses, workshops and symposia by pharmaceutical companies].
Warntjen M
Pathologe; 2010 Mar; 31(2):157-61. PubMed ID: 20198463
[No Abstract] [Full Text] [Related]
20. Patient assistance programs: information is not our enemy.
Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH
Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896
[No Abstract] [Full Text] [Related]
[Next] [New Search]